NCT00252668View on ClinicalTrials.gov

Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

September 30, 2005

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Etanercept

DRUG

Methotrexate

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00252668 - Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects | Biotech Hunter | Biotech Hunter